Research status of hyaluronan composite materials

doi:10.3969/j.issn.2095-4344.2015.21.023

Abstract

Abstract:

BACKGROUND: Hyaluronan with special linear macromolecular structure and rheologic property has good biocompatibility and becomes a signal matter of the cell surface, which possesses a promising application potential in tissue-engineering field.
OBJECTIVE: To review the research progress in medical hyaluronan composites.
METHODS: Related literatures concerning preparation, safety evaluation and clinical trials of hyaluronan composites were extensively reviewed and comprehensively analyzed in the three following aspects: cartilage scaffold, cornea scaffold and submucous bulking agent.
RESULTS AND CONCLUSION: The hyaluronan composite has a potential use in cartilage scaffold and cornea scaffold as its suitable porosity and pore size, biomimetic three-dimensional microstructure, excellent physical and chemical property and biological property. The hyaluronan composite as a bulking agent has been applied clinically, and results from some clinical trials have shown that the composite used as bulking agent has the problems about low efficacy and complications, which need to do further improvement. More researches are needed in product design, evaluation of performance and safety for expending and optimizing the clinical applications of the hyaluronan composite.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

Key words: Hyaluronic Acid, Stents, Tissue Engineering

CLC Number:

R318

Ding Jin-ju, Sun Wei-qing. Research status of hyaluronan composite materials [J]. Chinese Journal of Tissue Engineering Research, 2015, 19(21): 3403-3408.

Figures/Tables 1

References

[1] Noble PW.Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biology.2002;21(1):25-29.

[2] Laurent TC,Fraser JR.Hyaluronan.FASEB J.1992;6(7): 2397-2404.

[3] Grigorij K,Ladislav S,Robert S,et al.Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett.2007;29: 17-25.

[4] Robert L.Hyaluronan, a truly “youthful” polysaccharide.Its medical applications.PatholBiol(paris). 2014.doi:10.1016/j. patbio.2014.05.019.

[5] Luu HM,Chen A,Isayeva IS.Comparative stability of the bioresorbable ferric crosslinked hyaluronic acid adhesion prevention solutions. J Biomed Mater Res B ApplBiomater. 2013. 101(6):1006-1013.

[6] 刘清宇,王富友,杨柳.关节软骨组织工程支架的研究进展[J].中国修复重建外科杂志,2012, 26(10):1247-1250.

[7] Jiang Y,Chen L,Zhang S,et al.Incorporation of bioactive polyvinylpyrrolidone-iodine within bilayered collagen scaffolds enhances the differentiation and subchondralosteogenesis of mesenchymal stem cells.ActaBiomater.2013;9(9): 8089-8098.

[8] Laurent TC.Hyaluronan Research in Uppsala.Upsala J Med Sci.2007;112(2):123-142.

[9] Solchaga LA,Temenoff JS, Gao J,et al. Repair of osteochondral defectswith hyaluronan and polyester-based scaffolds.Osteoarthritis Cartilage.2005;13(4):297-309.

[10] Jeon YH,Choi JH,Sung JK,et al.Differenteffects of PLGA and chitosanscaffolds on human cartilage tissue engineering.J CraniofacSurg.2007;18(6):1249-1258.

[11] 张佼佼,王冬青,王志强,等.组织工程软骨支架材料的应用选择[J].中国组织工程研究与临床康复,2011,15(29):5467-5470.

[12] 许云飞,张仲文.复合胶原蛋白支架的研制[J].中国科技信息, 2014,26(3):122-124.

[13] Correia CR,Moreira-Teixeira LS,Moroni L,et al.Chitosan scaffolds containing hyaluronic acid for cartilage tissue engineering. Tissue Eng Part C Methods.2011;17(7): 717-730.

[14] Lee J,Choi YJ,Kim CH,et al.Articular cartilage repair with tissue-engineered hyaline cartilage reconstructed in a chitosan-hyaluronic acid scaffold by costal chondrocytes. Tissue Eng Regen Med.2011;8(5):446-453.

[15] 李音,颜廷亭,朱伟波,等.魔芋葡甘聚糖/透明质酸钠纤维膜生物性能的研究[J].材料导报,2013,27(14):90-92,112.

[16] 朱维波,王端诚,颜廷亭,等.透明质酸钠/魔芋葡甘聚糖复合多孔膜的制备及性能研究[J].材料导报,2014,28(4):38-41.

[17] Lebourg M,Martinez-Diaz S,Garcia-Giralt N,et al.Cell-free cartilage engineering approach using hyaluronic acid-polycaprolactone scaffolds: a study in vivo. J Biomater Appl.2014;28(9):1304-1315.

[18] 杨泽龙,陈竹,刘康,等.Ⅱ型胶原-透明质酸构建组织工程软骨复合三维纳米支架的体外实验研究[J].中国修复重建外科杂志, 2013,27(10):1240-1245.

[19] Luo HL,Lu YB,Wu TT,et al.Construction of tissue-engineered cornea composed of amniotic epithelial cells and acellular porcine cornea for treating corneal alkali burn. Biomaterials. 2013;34(28):6748-6759.

[20] Fan T,Ma X,Zhao J,et al.Transplantation of tissue-engineered human corneal endothelium in cat models.Mol Vis.2013;19: 400-407.

[21] Fan T,Zhao J, Ma X,et al.Establishment of a continuousuntransfected human corneal endothelial cell lineand its biocompatibility to denuded amniotic membrane. Mol Vis. 2011;17:469-480．

[22] Tamhane A,Vajpayee RB,Biswas NR,et al.Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns.Ophthalmology.2005;112(11):1963-1969.

[23] Kawano H,Sakamoto T,Ito T,et al.Hyaluronan protection of corneal endothelial cells against extracellular histones after phacoemulsification. J Cataract Refract Surg. 2014; 40(11): 1885-1893.

[24] Chen J,Li Q,Xu J,et al.Study on biocompatibility of complexes of collagen-chitosan-sodium hyaluronate and cornea.Artif Organs.2005;29(2):104-113.

[25] Shah A,Brugnano J,Sun S,et al.The development of a tissue engineered cornea: biomaterials and culture methods.Pediatr Res.2008;63(5):535-544.

[26] Fan T,Wang D,Fu Y,et al.Experimental studies on chitosan blend membrane as scaffold carriers for cultivating rabbit corneal endothelial cells in vitro.Sheng Wu Yi Xue Gong Cheng XueZaZhi.2009;26(5):1016-1020.

[27] Yao ZA,Wu HG.Characterization of chitosan-hyaluronic acid blended membranes and their effects on growth of keratocytes.PolymPolym Compos.2011;19(7): 573-580.

[28] 石鑫.仿去上皮羊膜微钠结构壳聚糖改性胶原-透明质酸复合电纺膜的研制及其性能研究[D]. 杭州:浙江大学医学院,2013.

[29] Tsai CC,Lin V,Tang L.Injectable biomaterials for incontinence and vesico-ureteral reflux: current status and future promise.J Biomed Mater Res B ApplBiomater.2006;77(1): 171-178.

[30] Mellgren A,Matzel KE,Pollack J,et al.Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.NeurogastroenterolMotil.2014;26(8):1087-1094.

[31] Chapple RC,Haab F,Cervigni M,et al.An open, Multicenter study of NASHA/Dx Gel (ZuidexTM) for the treatment of Stress Urinary Incontinence.Eur Urol.2005;48(3): 488-494.

[32] Lone F,Sultan AH,Thakar R.Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI).IntUrogynecol J.2010;21(11):1359-1364.

[33] Lightner D,Rovner E,Corcos J,et al.Randomized controlled multisite trial of injected bulking agents for women with Intrinsic Sphincter Deficiency: Mid-urethral Injection of Zuidex via the Implacer Versus Proximal Urethral Injection of ContigenCystoscopically. Urology.2009;74(4):771-777.

[34] Lightner DJ,Fox J,Klingele C.Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Urology. 2010;75(6):1310-1314.

[35] Bajpai M,Verma A,Panda SS.Endoscopic treatment of vesico-ureteral reflux: Experience of 99 ureteric moieties.J Indian Assoc Pediatr Surg.2013;18:133-135.

[36] Mellgren A,Matzel KE,Pollack J,et al.Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil.2014;26(8): 1087-1094.

[37] Khan F,Ahmad SR.Polysaccharides and Their Derivatives forVersatile Tissue Engineering Application.Macromol Biosci. 2013;13(4):395-421.

[38] 贵浩然,李澎,张卫国.制备软骨组织工程支架的材料和方法[J].中国组织工程研究,2013, 17(3):509-516.